Demographic, clinic, and histologic characteristics of the patients, demographic characteristics of the controls, the cytokines’ concentrations in the systemic circulation, and comparisons of the three groups
| Individuals/Diagnostic | Age(year)/Gender | Type/Site of the tumor | IL-2 (pg/mL) | IL-4 (pg/mL) | IL-10 (pg/mL) | TNF-α (pg/mL) |
|---|---|---|---|---|---|---|
| P1 (XP) | 31/F | BCC (nose) | 0.78 | 244 | 0 | 47.17 |
| P2 (XP) | 35/F | BCC + SCC (cheek) | 4.35 | 0 | 0 | 0 |
| P3 (XP) | 17/M | Multiple carcinomas (BCC + SCC) + melanoma (ear) | 2.38 | 0 | 0.01 | 27.83 |
| P4 (XP) | 11/F | Multiple carcinomas (BCC + SCC) face | 0.08 | 0 | 8.33 | 47 |
| P5 (XP) | 39/F | BCC (nasogenian furrow) | 0 | 0 | 0 | 30.33 |
| P6 (non-XP) | 42/M | BCC (cheek) | 4.77 | 4.48 | 0 | 0 |
| P7 (non-XP) | 59/F | SCC in situ (left side) | 0.76 | 0 | 23.50 | 0 |
| P8 (non-XP) | 74/M | SCC (nasogenian furrow) | 1.37 | 0 | 0.60 | 0 |
| P9 (non-XP) | 64/M | SCC (nose slot + right eye + chest) | 0.47 | 4.33 | 0 | 0 |
| P10 (non-XP) | 55/M | BCC (cheek) | 1.67 | 0 | 0 | 0 |
| P11 (non-XP) | 67/F | Multiple carcinomas BCC + SCC (face, cheek, and eyelids) | 3.51 | 0 | 7.17 | 0 |
| C1 (Control) | 57/F | - | 0.77 | 0 | 0 | 0 |
| C2 (Control) | 39/F | - | 0 | 0 | 0.03 | 0 |
| C3 (Control) | 45/F | - | 1.43 | 4.17 | 0 | 0 |
| Median concentrations of the cytokines | XP | 0.78 | 0.00 | 0.00 | 30.33 | |
| Non-XP | 1.52 | 0.00 | 0.30 | 0.00 | ||
| Control | 0.77 | 0.00 | 0.00 | 0.00 | ||
| Comparisons of the median plasma concentrations of the cytokines in the three subgroups | XP vs non-XP (P value) | 0.465 | 0.816 | 0.619 | 0.011 | |
| XP vs Controls (P value) | > 0.999 | 0.845 | 0.864 | 0.050 | ||
| Non-XP vs Controls (P value) | 0.796 | 0.795 | 0.396 | > 0.999 | ||
This work was supported by the Immunology, Dermatology and Oncology Department at INSERM Research Center 841, Henri Mondor Hospital, Créteil, France. We are grateful to Professor Armand Bensussan, Director of the Department, for having hosted us in his laboratory. We also wish to thank Professor Dragan Jovanovic of Mac Gill University, Canada, for helpful discussions. We also would like to thank Professor Scott King Johnson for language editing.
KA: Conceptualization, Data curation, Investigation, Methodology, Project administration, Validation, Writing—original draft. JB: Conceptualization, Formal analysis, Methodology, Validation, Writing—review & editing. FEM: Conceptualization, Investigation, Methodology, Validation, Writing—review & editing. HB: Conceptualization, Investigation, Methodology, Resources, Validation, Writing—review & editing. All the co-authors gave their final approval of the version to be published.
The authors have no conflicts of interest to declare.
Our study was approved by the Ethics Committee of A. Mami Hospital, Lariana, Tunisia. The study is in accordance with the Helsinki Declaration.
Informed consent to participate in the study was obtained from all the participants.
Not applicable.
All supporting data are available from the corresponding author upon request.
Not applicable.
© The Author(s) 2024.